Preferences help
enabled [disable] Abstract
Number of results
2008 | 3 | 1 | 9-19
Article title

Coffee consumption and type 2 diabetes - An extensive review

Title variants
Languages of publication
Coffee is a complex mixture of potentially active chemicals. It contains significant amounts of phenolic polymers, chlorogenic acid and also caffeine. Agricultural factors, roasting, blending, and brewing determine coffee’s chemical composition. Recent epidemiological studies suggest that habitual coffee consumption may help to prevent some chronic diseases including type 2 diabetes. Despite reports from the clinical trials of the effect of caffeine on decreasing insulin sensitivity, long-term prospective studies revealed that coffee may improve fasting glucose, glucose tolerance and insulin sensitivity as well. In the most recent publication habitual coffee drinkers have a lower total and cardiovascular mortality rate among diabetic subjects.
Physical description
1 - 3 - 2008
1 - 3 - 2008
  • [1] Wild S., Roglic G., Green A., Sicree R., King H., Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 2004, 27, 1047–1053[Crossref]
  • [2] Amos A.F., McCarty D.J. and Zimmet P., The rising global burden of diabetes and its complications: Estimates and projections to the year 2010, Diabet. Med., 1997, 14, S7–S85<S7::AID-DIA522>3.3.CO;2-I[Crossref]
  • [3] Bennett P.H., Type 2 diabetes among the Pima Indians of Arizona: an epidemic attributable to environmental change, Nutrition Reviews, 1999, 57, S51–54[Crossref]
  • [4] Lako J.V., Nguyen V.C., Dietary patterns and risk factors of diabetes mellitus among urban indigenous women in Fiji, Asia Pacific J. of Clin. Nutr., 2001, 10, 188–193[Crossref]
  • [5] Hetzel B., Michael T., The lifestyle factor: Lifestyle and health, Melbourne Pinguin, 1987.
  • [6] Tuomilehto J., Tuomilehto-Wolf E., Zimmet P., Alberti K.G.M.M., Knowler W.C., Primary prevention of diabetes mellitus, In: Alberti K.G.M.M., Zimmet P., DeFronzo R.A., Keen H. (Eds.) International Textbook of Diabetes Mellitus, 2nd ed., Wiley, Chichester New York Brisban Toronto, 1997
  • [7] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence and dietary burden, J. Sci. Food Agric., 1999, 79, 362–372<362::AID-JSFA256>3.0.CO;2-D[Crossref]
  • [8] Clifford M.N., Chlorogenic acid and other cinnamates-nature, occurrence, dietary burden, absorption and metabolism, J. Sci. Food Agric., 2000, 80, 1033–1043<1033::AID-JSFA595>3.0.CO;2-T[Crossref]
  • [9] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993 91, 301–307
  • [10] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes”, Diabetes, 2001, 50, 2497–2504[Crossref]
  • [11] Tuomilehto J., Tuomilehto-Wolf E., Virtala E., LaPorte R., Coffee consumption as trigger for insulin dependent diabetes mellitus in childhood, B.M.J., 1990, 300, 642–643
  • [12] Barbagallo M., Dominguez L.J., Galioto A., Ferlisi A., Cani C., Malfa L., et al., Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X, Mol. Aspects Med., 2003, 24, 39–52[Crossref]
  • [13] Paolisso G., Scheen A., D’Onofrio F., Lefebvre P., Magnesium and glucose homeostasis, Diabetologia, 1990, 33, 511–514[Crossref]
  • [14] Paolisso G., Ravussin E., Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians, J. Clin. Endocrinol. Metab., 1995, 80, 1382–1385[Crossref]
  • [15] Paolisso G., Barbagallo M., Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium, Am. J. Hypertens., 1997, 10, 346–355[Crossref]
  • [16] Matsui T., Ueda T., Oki T., Sugita K., Terahara N., Matsumoto K., alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. Alpha-Glucosidase inhibition by isolated acylated anthocyanins, J. Agric. Food. Chem., 2001, 49, 1952–1956[Crossref]
  • [17] Kobayashi Y., Suzuki M., Satsu H., Arai S., Hara Y., Suzuki K., et al., Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism, J. Agric. Food. Chem., 2000, 48, 5618–5623[Crossref]
  • [18] Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W., Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus, J. Clin. Invest., 1993, 91, 301–307 [Crossref]
  • [19] Meier J.J., Hucking K., Holst J.J., Deacon C.F., Schmiegel W.H., Nauck M.A., Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes, Diabetes, 2001, 50, 2497–2504[Crossref]
  • [20] Newgard C.B., Foster D.W., McGarry J.D., Evidence for suppression of hepatic glucose-6-phosphatase with carbohydrate feeding, Diabetes, 1984, 33, 192–195[Crossref]
  • [21] Youn J.H., Youn M.S., Bergman R.N., Synergism of glucose and fructose in net glycogen synthesis in perfused rat livers, J. Biol. Chem., 1986, 261, 15960–15969
  • [22] Arion W.J., Canfield W.K., Ramos F.C., Schindler P.W., Burger H.J., Hemmerle H., et al., Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase, Arch. Biochem. Biophys., 1997, 339, 315–322[Crossref]
  • [23] Andrade-Cetto A., Wiedenfeld H., Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats, J. Ethnopharmacol., 2001, 78, 145–149[Crossref]
  • [24] Keijzers G.B., De Galan B.E., Tack C.J., Smits P., Caffeine can decrease insulin sensitivity in humans, Diabetes Care, 2002, 25, 364–369[Crossref]
  • [25] Denaro C.P., Brown C.R., Jacob P., Benowitz N.L., Effects of caffeine with repeated dosing, Eur. J. Clin. Pharmacol., 1991, 40, 273–278[Crossref]
  • [26] Arnlov J., Vessby B., Riserus U., Coffee consumption and insulin sensitivity, JAMA, 2004, 291, 1199–1201.[Crossref]
  • [27] Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M., Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers, Diabetes Care, 2002, 23, 171–175[Crossref]
  • [28] Laakso M., How good is insulin level for insulin resistance?, Am. J. Epidemiol., 1992, 137, 959–965
  • [29] Ferrannini E. Mari A., How to measure insulin sensitivity, J. Hypertens., 1998, 16, 895–906[Crossref]
  • [30] Haffner S.M., Valdez R.A., Hazuda H.P., Mitchell B.D., Moralles P.A. Stern M.P., Prospective analaysis of the insulin-resistance syndrome (syndrome X), Diabetes, 1992, 41, 715–722[Crossref]
  • [31] Zavaroni I., Bonora E., Pagliara M., Dall’Aglio E., Luchetti L., Buonanno G., et al., Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance, N. Eng. J. Med., 1989, 320, 702–706[Crossref]
  • [32] Despres J.P., Lamarch B., Maurige P., Cantin B., Dagenais G.R., Moorjani S., et al., Hyperinsulinemia as an independent risk factor for ischemic heart disease, N. Eng. J. Med., 1996, 334, 952–957[Crossref]
  • [33] Fontbonne A., Charles M.A., Thibult N., Richard J.L., Claude J.R., Warnet J.M., et al., Hyperinsulinemia as a predictor of coronary heart disease mortality in healthy population: the Paris Prospective Study, 15-year follow-up, Diabetologia, 1991, 34, 356–361[Crossref]
  • [34] Panagiotakos D.B., Pitsavos C., Zampelas A., Zeimbekis A., Chrysohoou C., Papademetriou L., et al., The association between coffee consumption and plasma total homocysteine levels: the “ATTICA” study, Heart. Vessels., 2004, 19, 280–286[Crossref]
  • [35] Panagiotakos D.B., Pitsavos C,. Zeimbekis A., Chrysohoou C., Stefanadis C., The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the “ATTICA” Study, Int. J. Cardiol., 2005, 98, 471–477[Crossref]
  • [36] Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., Selhub J., Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort, Am. J. Clin. Nutr., 2001, 73, 613–621
  • [37] Martos R., Valle M., Morales R., Canete R., Gavilan M.I., Sanchez-Margalet V., Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children, Metabolism., 2006, 55, 72–77[Crossref]
  • [38] Cho N.H., Lim S., Jang H.C., Park H.K., Metzger B.E., Elevated homocysteine as a risk factor for the development of diabetes in women with a previous history of gestational diabetes mellitus: a 4-year prospective study, Diabetes Care., 2005, 28, 2750–2755[Crossref]
  • [39] Peyrin-Biroulet L., Gueant J.L., Roblin X., Coffee and diabetes: is homocysteine the missing link?, Arch. Intern. Med., 2007, 167, 204[Crossref]
  • [40] Mascitelli L., Pezzetta F., Sullivan J.L., Inhibition of iron absorption by coffee and the reduced risk of type 2 diabetes mellitus, Arch. Intern. Med., 2007, 167, 204–205[Crossref]
  • [41] Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., Hu F.B., Body iron stores in relation to risk of type 2 diabetes in apparently healthy women, JAMA., 2004, 291, 711–717[Crossref]
  • [42] Facchini F.S., Saylor K.L., Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate intolerant patients, Ann. N. Y. Acad. Sci. 2002, 967, 342–351[Crossref]
  • [43] Petrie H.J., Chown S.E., Belfie L.M., Duncan A.M., McLaren D.H., Conquer J.A., et al., Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss, Am. J. Clin. Nutr., 2004, 80, 22–28
  • [44] Graham T.E., Sathasivam P., Rowland M., Marko N., Greer F., Battram D., Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test, Can. J. Physiol. Pharmacol., 2001, 79, 559–565[Crossref]
  • [45] Greer F., Hudson R., Ross R., Graham T., Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans, Diabetes, 2001, 50, 2349–2354[Crossref]
  • [46] Naismith, D.J., Akinyanju, P.A., Szanto, S., Yudkin J., The effect in volunteers of coffee and decaffeinated coffee on blood glucose, insulin, plasma lipids and some factors involved in blood clotting, Nutr. Metab., 1970, 12, 144–151[Crossref]
  • [47] Van Dam R.M., Pasman W.J., Verhoef P., Effects of coffee consumption on fasting blood glucose and insulin concentrations: randomized controlled trials in healthy volunteers, Diabetes Care, 2004, 27, 2990–2992[Crossref]
  • [48] Battram D.S., Arthur R., Weekes A., Graham T.E., The glucose intolerance induced by caffeinated coffee ingestion is less pronounced than that due to alkaloid caffeine in men, J. Nutr., 2006, 136, 1276–1280
  • [49] Yamaji T., Mizoue T., Tabata S., Ogawa S., Yamaguchi K., Shimizu E., et al., Coffee consumption and glucose tolerance status in middle-aged Japanese men, Diabetologia, 2004, 47, 2145–2151[Crossref]
  • [50] Soriguer F., Rojo-Martinez G., de Antonio I.E., Coffee consumption and type 2 diabetes mellitus, Ann. Intern. Med. 2004, 141, 321–323
  • [51] Agardh E.E., Carlsson S., Ahlbom A., Efendic S., Grill V., Hammar N., et al., Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women, J. Intern. Med., 2004, 255, 645–652[Crossref]
  • [52] Van Dam R.M., Dekker J.M., Nijpels G., Stehouwer C.D., Bouter L.M., Heine R.J., Hoorn study: “Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study, Diabetologia, 2004, 47, 2152–2159[Crossref]
  • [53] Bidel S., Hu G., Sundvall J., Kaprio J., Tuomilehto J., Effects of coffee consumption on glucose tolerance and serum glucose and insulin levels-A cross sectional analysis, Horm. Metab. Res., 2006, 38, 38–43[Crossref]
  • [54] Van Dam R.M., Feskens E.J., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2002, 360, 1477–1478[Crossref]
  • [55] Salazar-Martinez E., Willett W.C., Ascherio A., Manson J.E., Leitzmann M.F., Stampfer M.J., et al., Coffee consumption and risk for type 2 diabetes mellitus, Ann. Intern. Med., 2004, 140, 1–8
  • [56] Carlsson S., Hammar N., Grill V., Kaprio J., Coffee consumption and risk of type 2 diabetes in Finnish twins, Int. J. Epidemiol., 2004, 3, 616–617[Crossref]
  • [57] Rosengren A., Dotevall A., Wilhelmsen L., Thelle D., Johansson S., Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow up study, J. Intern. Med., 2004, 255, 89–95[Crossref]
  • [58] Paynter N.P., Yeh H.C., Voutilainen S., Schmidt M.I., Heiss G., Folsom A.R., et al., Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study, Am. J. Epidemiol., 2006, 164, 1075–1084[Crossref]
  • [59] Pereira M.A., Parker E.D., Folsom A.R., Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women, Arch. Intern. Med., 2006, 166, 1311–1316[Crossref]
  • [60] Van Dam R.M., Willett W.C., Manson J.E., Hu F.B., Coffee, Caffeine, and Risk of Type 2 Diabetes: A prospective cohort study in younger and middle-aged U.S. women, Diabetes Care, 2006, 29, 398–403[Crossref]
  • [61] Iso H., Date C., Wakai K., Fukui M., Tamakoshi A., The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults, Ann. Intern. Med., 2006, 144, 554–562
  • [62] Reunanen A., Heliovaara M., Aho K., Coffee consumption and risk of type 2 diabetes mellitus, Lancet, 2003, 361, 702–703[Crossref]
  • [63] Tuomilehto J., Hu G., Bidel S., Lindstrom J., Jousilahti P., Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women, JAMA, 2004, 291, 1213–1219[Crossref]
  • [64] Saremi A., Tulloch-Reid M., Knowler W.C., Coffee consumption and the incidence of type 2 diabetes”, Diabetes Care, 2003, 7, 2211–2212[Crossref]
  • [65] Van Dam R.M., Hu F.B., Coffee consumption and risk of type 2 diabetes: a systematic review, JAMA, 2005, 294, 97–104[Crossref]
  • [66] Hu G., Jousilahti P., Peltonen M., Bidel S., Tuomilehto J., Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland, Int. J. Obes., 2006, 30, 1742–1749[Crossref]
  • [67] Perry I.J., Wannamethee S.G., Sharper A.G., Prospective study of serum g-glutamyltransferase and risk of NIDDM, Diabetes Care, 1998, 21,732–737[Crossref]
  • [68] Nakanishi N., Suzuki K., Tatar K., Serum g-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men, Diabetes Care, 2004, 27, 1427–1432[Crossref]
  • [69] Bidel S., Silventoinen K., Hu G., Lee D.H., Kaprio J., Tuomilehto J., Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes, Eur. J. Clin. Nutr., 2007, doi:10.1038/sj.ejcn.1602712, 1–8 [Crossref]
  • [70] Lee D.H., Jacobs D.R. Jr., Gross M., Kiefe C.I., Roseman J., Lewis C.E., et al., Gammaglutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study, Clin. Chem., 2003, 49, 1358–1366[Crossref]
  • [71] Bidel S., Hu G., Qiao Q., Jousilahti P., Antikainen R., Tuomilehto J., Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes, Diabetologia, 2006, 49, 2618–2626[Crossref]
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.